Inside the Halls of Innovation: Conference Coverage and Competitive Insights on Oncology Assets

Objective: Setting the Stage for Strategic Insight

In today’s fast-moving oncology landscape, staying ahead of emerging data, trial read-outs, and competitive moves is vital. The aim of this case study is to illustrate how DelveInsight partnered with a major pharma player to deliver conference coverage at key oncology meetings specifically AACR Annual Meeting, ASCO Annual Meeting and ESMO Congress for a portfolio of oncology assets. The objective: to support the client in pre-conference planning, real-time intelligence gathering during the forums, and post-conference analysis, enabling actionable decision-making in the oncology asset space. 

Problem Statement: The Challenge of Capturing Real-Time Oncology Intelligence

For a large-cap pharmaceutical company focused on oncology, the sheer volume of data emerging from multiple congresses presents a challenge: how to identify the most relevant sessions, track competitive assets, assess implications for their own portfolio, and deliver timely insights to senior stakeholders. Without a structured approach, the company risked missing key developments, lagging competitor responses, and failing to align internal strategy with external scientific momentum.

Our Approach: Methodology (AIR-Specific: Acquire, Interpret, Recommend)

• Acquire: DelveInsight began with comprehensive pre-conference planning identifying critical sessions, abstracts and speakers aligned with the client’s indications of interest. During each congress, live monitoring was conducted: tracking posters, oral presentations, social media sentiment, and competitor booth intelligence.
• Interpret: The team analysed the captured intelligence in real time, mapped competitor trial updates and regulatory signals, and distilled “Key Intelligence Topics (KITs)” and “Key Intelligence Questions (KIQs)” tailored to the client’s strategic priorities.
• Recommend: Post-conference, DelveInsight delivered structured reports and strategic briefings, translating raw data into business implications. This included competitive benchmarking, on-asset opportunities, and actionable recommendations to senior stakeholders.

Results: Impact and Takeaways

The structured AIR-method delivered strong results:

• The client was able to proactively respond to competitor activities based on real-time intelligence captured at AACR, ASCO and ESMO. 
• Their internal leadership received timely updates and detailed analysis, enabling more informed strategic decisions and improved alignment.
• With DelveInsight’s expertise in conference coverage, the client strengthened its competitive positioning by aligning internal strategy with emerging science

What DelveInsight Offers

DelveInsight delivers tailored congress-and-conference coverage services across the oncology landscape from pre-event planning and live monitoring to post-event strategic analysis. By leveraging deep sector expertise, real-time tracking and actionable deliverables, they help clients transform volumes of scientific data into clear business intelligence, enabling competitive advantage in the evolving oncology market.

In summary, this case study demonstrates how a structured AIR-based methodology Acquire, Interpret, Recommend supported by DelveInsight’s deep oncology specialization, enabled a pharma client to navigate the complexity of major oncology conferences and convert emerging scientific intelligence into strategic business advantage.